Wu Haibing

Wu Haibing（吳海兵), has been appointed as an independent non-executive Director since November 2018. Mr. Wu has over 18 years of experience in finance. Mr Wu has been serving as the investment partner of Sequoia Capital since June 2019. Previously, Mr. Wu served as a partner of VKC-Partners（嘉禦基金）and the chief financial officer of Plateno Hotel Group (previously known as “7 Days Group Holdings Limited”), a company whose shares were then listed on the New York Stock Exchange (stock symbol: SVN) and voluntarily delisted in July 2013. Mr. Wu is a non-practicing member of Shanghai Institute of Certified Public Accountant.

Mr. Wu has served as an independent director of Shanghai MicroPort Endovascular MedTech Co., Ltd., a company whose shares are listed on Shanghai Stock Exchange (stock code: 688016) since July 2018, an independent director and a member of audit committee of CooTek (Cayman) Inc., a company whose shares are listed on the New York Stock Exchange (stock symbol: CTK) since September 2018, an independent director of Acorn International, Inc.（橡果國際股份有限公司）from October 2016 to January 2021, a company whose shares are listed on the New York Stock Exchange (stock symbol: ATV) and was privatized in January 2021.

Mr. Wu received his bachelor’s degree in economics from Shanghai Jiao Tong University （上海交通大學） in the PRC in July 1994 and a master’s degree in business administration from Michigan State University in the United States in May 2000.

Mr. Wu received his bachelor's degree in economics from Shanghai Jiao Tong University (上海交通大學) in July 1994 and a master's degree in business administration from Michigan State University in May 2000.